ELOY DEL
POTRO GÓMEZ
Investigador hasta 2016
Publicaciones (45) Publicaciones en las que ha participado algún/a investigador/a
2017
-
Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols
Leukemia and Lymphoma, Vol. 58, Núm. 1, pp. 145-152
2014
-
Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: Parallel study of 81 patients
Leukemia and Lymphoma, Vol. 55, Núm. 10, pp. 2341-2348
-
Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols
Cancer, Vol. 120, Núm. 24, pp. 3958-3964
-
Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: Final results of the PETHEMA ALL-AR-03 trial
Journal of Clinical Oncology, Vol. 32, Núm. 15, pp. 1595-1604
2010
-
Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial
Haematologica, Vol. 95, Núm. 1, pp. 87-95
-
Linezolid treatment of a prosthetic joint infection with Staphylococcus lugdunensis in a patient with multiple myeloma
International Journal of Antimicrobial Agents
-
Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA study group
Haematologica, Vol. 95, Núm. 4, pp. 589-596
2008
-
Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the programa Español de tratamiento en hematología pediatric-based protocol ALL-96
Journal of Clinical Oncology, Vol. 26, Núm. 11, pp. 1843-1849
2007
-
Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 trial
Journal of Clinical Oncology, Vol. 25, Núm. 1, pp. 16-24
-
Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia
European Journal of Haematology, Vol. 78, Núm. 2, pp. 102-110
2006
-
Significado pronóstico de los subtipos inmunológicos de la leucemia aguda linfoblástica T del adulto. Estudio de 81 pacientes
Medicina Clinica, Vol. 126, Núm. 2, pp. 41-46
2005
-
Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial
Haematologica, Vol. 90, Núm. 10, pp. 1346-1356
-
Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study
Haematologica, Vol. 90, Núm. 7, pp. 990-992
-
Prevalencia y significado pronóstico de los marcadores mieloides en adultos con leucemia aguda linfoblástica de alto riesgo
Medicina Clinica, Vol. 125, Núm. 7, pp. 241-246
2002
-
Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial
Haematologica, Vol. 87, Núm. 2, pp. 154-166
2001
-
Tratamiento de la leucemia aguda linfoblástica en adultos
Revisiones en Cancer, Vol. 15, Núm. 6, pp. 225-230
2000
-
Association of t(9;11)-MLL AF9 and trisomy 8 in an AML-M5 preceded by pancytopenia
Cancer Genetics and Cytogenetics, Vol. 120, Núm. 2, pp. 144-147
1999
-
Mieloma múltiple y otras discrasias de células plasmáticas
Revista Clinica Espanola, Vol. 199, Núm. SUPPL. 1, pp. 52-57
-
Relación entre la persistencia del gen BCR/ABL y la recaída en pacientes adultos con leucemia linfoblástica aguda
Medicina Clinica, Vol. 112, Núm. 13, pp. 481-484
1998
-
Detection of bcr/abl mRNA in a case of chronic myelogenous leukemia in long-term remission: CML or sensitivity of detection?
Haematologica, Vol. 83, Núm. 8, pp. 744-747